Paul Tudor Jones Biocryst Pharmaceuticals Inc Transaction History

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 99,450 shares of BCRX stock, worth $915,934. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,450

Holding current value

$915,934

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.03 - $8.43 $699,133 - $838,363	99,450 New	99,450 $747,000
Q2 2024 Aug 14, 2024	BUY	$4.13 - $6.79 $425,398 - $699,383	103,002 New	103,002 $636,000
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $575,040 - $781,731	115,470 Added 122.27%	209,905 $1.26 Million
Q3 2023 Nov 15, 2023	BUY	$6.71 - $7.92 $119,256 - $140,762	17,773 Added 23.18%	94,435 $668,000
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $533,567 - $675,392	76,662 New	76,662 $539,000
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $742,546 - $1.02 Million	68,818 Added 286.01%	92,879 $1.17 Million
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $189,841 - $430,210	24,061 New	24,061 $255,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $1.47 Million - $2.03 Million	-131,066 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $968,667 - $1.2 Million	68,168 Added 108.38%	131,066 $1.88 Million
Q2 2021 Aug 16, 2021	BUY	$9.5 - $17.24 $47,319 - $85,872	4,981 Added 8.6%	62,898 $994,000
Q1 2021 May 17, 2021	BUY	$7.37 - $13.61 $426,848 - $788,250	57,917 New	57,917 $589,000
Q2 2020 Aug 14, 2020	SELL	$1.9 - $5.61 $93,293 - $275,462	-49,102 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $166,408 - $427,460	-104,005 Reduced 67.93%	49,102 $98,000
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $149,394 - $324,158	93,959 Added 158.85%	153,107 $528,000
Q3 2019 Nov 14, 2019	BUY	$2.5 - $3.73 $55,702 - $83,108	22,281 Added 60.44%	59,148 $169,000
Q2 2019 Aug 14, 2019	BUY	$2.91 - $9.15 $107,282 - $337,333	36,867 New	36,867 $140,000
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $426,375 - $546,293	-102,494 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $420,225 - $611,889	102,494	102,494 $537,000

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

167M

Call Options Held

728K

Put Options Held

989K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.71B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account